1. Home
  2. ITGR vs CNS Comparison

ITGR vs CNS Comparison

Compare ITGR & CNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITGR
  • CNS
  • Stock Information
  • Founded
  • ITGR 1970
  • CNS 1986
  • Country
  • ITGR United States
  • CNS United States
  • Employees
  • ITGR N/A
  • CNS N/A
  • Industry
  • ITGR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CNS Investment Managers
  • Sector
  • ITGR Health Care
  • CNS Finance
  • Exchange
  • ITGR Nasdaq
  • CNS Nasdaq
  • Market Cap
  • ITGR 4.2B
  • CNS 4.2B
  • IPO Year
  • ITGR 2000
  • CNS 2004
  • Fundamental
  • Price
  • ITGR $121.00
  • CNS $78.01
  • Analyst Decision
  • ITGR Strong Buy
  • CNS Sell
  • Analyst Count
  • ITGR 10
  • CNS 4
  • Target Price
  • ITGR $145.90
  • CNS $77.50
  • AVG Volume (30 Days)
  • ITGR 432.8K
  • CNS 195.2K
  • Earning Date
  • ITGR 07-24-2025
  • CNS 07-16-2025
  • Dividend Yield
  • ITGR N/A
  • CNS 3.18%
  • EPS Growth
  • ITGR N/A
  • CNS 18.98
  • EPS
  • ITGR 2.18
  • CNS 3.06
  • Revenue
  • ITGR $1,746,192,000.00
  • CNS $529,174,000.00
  • Revenue This Year
  • ITGR $11.03
  • CNS $5.81
  • Revenue Next Year
  • ITGR $7.29
  • CNS $12.38
  • P/E Ratio
  • ITGR $54.76
  • CNS $25.51
  • Revenue Growth
  • ITGR 10.19
  • CNS 8.82
  • 52 Week Low
  • ITGR $104.93
  • CNS $68.99
  • 52 Week High
  • ITGR $146.36
  • CNS $110.67
  • Technical
  • Relative Strength Index (RSI)
  • ITGR 52.31
  • CNS 54.44
  • Support Level
  • ITGR $119.56
  • CNS $73.85
  • Resistance Level
  • ITGR $123.49
  • CNS $78.53
  • Average True Range (ATR)
  • ITGR 2.19
  • CNS 1.97
  • MACD
  • ITGR 0.18
  • CNS 0.31
  • Stochastic Oscillator
  • ITGR 63.56
  • CNS 89.55

About ITGR Integer Holdings Corporation

Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.

About CNS Cohen & Steers Inc

Cohen & Steers is a niche asset manager concentrating on real estate securities. The firm invests mainly in the equity shares of real estate investment trusts, with holdings in domestic and international real estate securities accounting for close to two thirds of its $79.3 billion in managed assets at the end of January 2024. Cohen & Steers also manages portfolios dedicated to preferred securities, utilities stocks, and other high-yield offerings. The firm's distribution is balanced among its closed-end funds, open-end funds, and institutional accounts. During the past four calendar quarters, the company garnered 42% (27%) of its managed assets (base management fees) from institutional clients, 45% (52%) from open-end funds, and 13% (21%) from closed-end funds.

Share on Social Networks: